Back to today’s briefing

Story perspectives

Revolutionary Cancer Treatment: Reprogramming Neutrophils Unveiled

7/29/2025

50 9

Summary

Story summary

Neutrophils are complex players in the cancer arena, capable of either fueling or fighting tumor growth depending on their surroundings. A recent review from Zhejiang University uncovers their transformation into anti-tumor (N1) and pro-tumor (N2) states, suggesting new therapeutic targets. Reprogramming these immune cells could revolutionize cancer treatment, ushering in a new era of personalized oncology.

1 of 1

Story summary

Neutrophils are complex players in the cancer arena, capable of either fueling or fighting tumor growth depending on their surroundings. A recent review from Zhejiang University uncovers their transformation into anti-tumor (N1) and pro-tumor (N2) states, suggesting new therapeutic targets. Reprogramming these immune cells could revolutionize cancer treatment, ushering in a new era of personalized oncology.